Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas (@ITarnanas) / Twitter
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas (@ITarnanas) / Twitter
Greek Researcher Receives Top European Innovation Award (video)
The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
ADDF Awards $15 Million in New Investments Supporting Wide Range of Innovative Alzheimer's Research | Alzheimer's Drug Discovery Foundation
The power to innovate: winners of EIT Awards 2018 announced | EIT
Interview with venture case winner Alterniity: We didn't fly too high or too low”
EIT Awards Winners | European Institute of Innovation & Technology (EIT)
EIT Awards Winners | European Institute of Innovation & Technology (EIT)
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Sabine Schumann on Twitter: "Congrats to @EITHealth innovator Ioannis Tarnanas @altoida predicting #Alzheimer disease for winning the @EITeu innovator award 👏 🏆 #InnovEIT https://t.co/8Tag4JkgBe" / Twitter
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute
Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
